Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

som.uci.edu

Founded Year

1896

Stage

Grant | Alive

Total Raised

$9M

Last Raised

$9M | 4 yrs ago

About University of California, Irvine, School of Medicine

The University of California, Irvine School of Medicine is an LCME accredited medical school, co-located in Orange County's cities of Irvine on the University of California, Irvine campus and Orange at the UC Irvine Medical Center.

University of California, Irvine, School of Medicine Headquarters Location

1001 Health Sciences Rd

Irvine, California, 92617,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest University of California, Irvine, School of Medicine News

AnHeart Therapeutics to Present Poster and Host Investigator Meeting at WCLC 2022

Aug 4, 2022

August 04, 2022 09:58 AM Eastern Daylight Time NEW YORK--( BUSINESS WIRE )-- AnHeart Therapeutics today announced it will host an investigator meeting in addition to a e-poster presentation at the World Conference on Lung Cancer (WCLC) in Vienna, Austria at 11:00 am ET on Sunday, Aug. 7, 2022. Ignatius Ou, M.D., Ph.D., Professor of Medical Oncology, University of California Irvine School of Medicine, along with members of AnHeart’s clinical development team and study investigators, will discuss the most recent clinical data of taletrectinib and the current status of the TRUST-II clinical trial for its ROS-1 inhibitor taletrectinib in ROS1-positive non-small cell lung cancer (NSCLC). Taletrectinib received FDA granted Breakthrough Therapy Designation (BTD) for the treatment of adult patients with advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who are ROS1 tyrosine kinase inhibitor (TKI) treatment naïve or previously treated with crizotinib. Details of the e-poster presentation at WCLC 2022: Abstract Title: TRUST-II: A Global Phase II Study for Taletrectinib in ROS1-fusion Positive Lung Cancer and Other Solid Tumors Session: EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments Final Program #: EP08.02-118 Author: Misako Nagasaka, M.D. Ph.D., University of California Irvine, School of Medicine E-posters will be displayed on both days of the conference from August 7-8, 2022, 09:45 – 18:00. For more information, visit: https://wclc2022.iaslc.org/ . The e-poster, as with other selected presentations regarding developments in AnHeart’s business given by management at certain investor and medical conferences, can be found on the company’s website, www.anhearttherapeutics.com , under Publications. ABOUT ANHEART THERAPEUTICS AnHeart Therapeutics (“AnHeart”) is a clinical-stage global biopharmaceutical group company developing a broad pipeline of novel precision oncology therapeutics with high unmet medical needs. Its lead asset, taletrectinib, is a potential best-in-class next-generation ROS1 inhibitor currently in Phase 2 trials for ROS1 TKI-naïve and TKI-pretreated patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC). The Company’s pipeline also includes AB-218, a mIDH1 inhibitor in Phase 2 trials with good brain penetration for multiple solid tumors with mIDH1 mutations and AB-329, an AXL inhibitor in Phase 1 studies to be used in combination with checkpoint inhibitor or chemotherapies in NSCLC or other solid tumors. The Company operates from offices in the US and China. For more information, please visit https://www.anhearttherapeutics.com/ .

University of California, Irvine, School of Medicine Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

University of California, Irvine, School of Medicine Rank

  • When was University of California, Irvine, School of Medicine founded?

    University of California, Irvine, School of Medicine was founded in 1896.

  • Where is University of California, Irvine, School of Medicine's headquarters?

    University of California, Irvine, School of Medicine's headquarters is located at 1001 Health Sciences Rd, Irvine.

  • What is University of California, Irvine, School of Medicine's latest funding round?

    University of California, Irvine, School of Medicine's latest funding round is Grant.

  • How much did University of California, Irvine, School of Medicine raise?

    University of California, Irvine, School of Medicine raised a total of $9M.

  • Who are the investors of University of California, Irvine, School of Medicine?

    Investors of University of California, Irvine, School of Medicine include National Institute on Drug Abuse.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.